Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Sep, 2018 | Pages:
117 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
This report studies the global market size of Bio-pharma in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bio-pharma in these regions. This research report categorizes the global Bio-pharma market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. In 2017, the global Bio-pharma market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Bio-pharma market based on company, product type, application and key regions. The various contributors involved in the value chain of Bio-pharma include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Bio-pharma include • Pfizer • F. Hoffmann-La Roche AG • Johnson & Johnson Services • Sanofi, Amgen • AbbVie • Merck & Co., Inc • Biogen Idec • Bayer AG • Eli Lilly and Company • Novartis AG GlaxoSmithKline Plc • Bristol-Myers Squibb Company • AstraZeneca PLC • Abbott Laboratories Market Size Split by Type • Monoclonal Antibodies • Recombinant Proteins • Granulocyte-Colony Stimulating Factor (G-CSF) • Interferons • Recombinant Human Insulin • Erythropoietin • Vaccines • Growth Hormones • Purified Proteins • Others Market Size Split by Application • Metabolic Disorders • Oncology • Neurological Disorders • Cardiovascular Diseases • Inflammatory and Infectious Diseases • Others Market size split by Region • North America • United States • Canada • Mexico • Asia-Pacific • China • India • Japan • South Korea • Australia • Indonesia • Singapore • Malaysia • Philippines • Thailand • Vietnam • Europe • Germany • France • UK • Italy • Spain • Russia • Central & South America • Brazil • Rest of Central & South America • Middle East & Africa • GCC Countries • Turkey • Egypt • South Africa The study objectives of this report are: • To study and analyze the global Bio-pharma market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. • To understand the structure of Bio-pharma market by identifying its various subsegments. • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). • Focuses on the key global Bio-pharma manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. • To analyze the Bio-pharma with respect to individual growth trends, future prospects, and their contribution to the total market. • To project the value and volume of Bio-pharma submarkets, with respect to key regions (along with their respective key countries). • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. • To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Bio-pharma are as follows: • History Year: 2013-2017 • Base Year: 2017 • Estimated Year: 2018 • Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bio-pharma market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Bio-pharma Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Bio-pharma Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Recombinant Proteins
1.4.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.4.5 Interferons
1.4.6 Recombinant Human Insulin
1.4.7 Erythropoietin
1.4.8 Vaccines
1.4.9 Growth Hormones
1.4.10 Purified Proteins
1.4.11 Others
1.5 Market by Application
1.5.1 Global Bio-pharma Market Size Growth Rate by Application
1.5.2 Metabolic Disorders
1.5.3 Oncology
1.5.4 Neurological Disorders
1.5.5 Cardiovascular Diseases
1.5.6 Inflammatory and Infectious Diseases
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bio-pharma Market Size
2.1.1 Global Bio-pharma Revenue 2016-2025
2.1.2 Global Bio-pharma Sales 2016-2025
2.2 Bio-pharma Growth Rate by Regions
2.2.1 Global Bio-pharma Sales by Regions
2.2.2 Global Bio-pharma Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Bio-pharma Sales by Manufacturers
3.1.1 Bio-pharma Sales by Manufacturers
3.1.2 Bio-pharma Sales Market Share by Manufacturers
3.1.3 Global Bio-pharma Market Concentration Ratio (CR5 and HHI)
3.2 Bio-pharma Revenue by Manufacturers
3.2.1 Bio-pharma Revenue by Manufacturers (2016-2018)
3.2.2 Bio-pharma Revenue Share by Manufacturers (2016-2018)
3.3 Bio-pharma Price by Manufacturers
3.4 Bio-pharma Manufacturing Base Distribution, Product Types
3.4.1 Bio-pharma Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bio-pharma Product Category
3.4.3 Date of International Manufacturers Enter into Bio-pharma Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Bio-pharma Sales by Type
4.2 Global Bio-pharma Revenue by Type
4.3 Bio-pharma Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Bio-pharma Breakdown Data by Application
6 North America
6.1 North America Bio-pharma by Countries
6.1.1 North America Bio-pharma Sales by Countries
6.1.2 North America Bio-pharma Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Bio-pharma by Type
6.3 North America Bio-pharma by Application
6.4 North America Bio-pharma by Company
7 Europe
7.1 Europe Bio-pharma by Countries
7.1.1 Europe Bio-pharma Sales by Countries
7.1.2 Europe Bio-pharma Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bio-pharma by Type
7.3 Europe Bio-pharma by Application
7.4 Europe Bio-pharma by Company
8 Asia Pacific
8.1 Asia Pacific Bio-pharma by Countries
8.1.1 Asia Pacific Bio-pharma Sales by Countries
8.1.2 Asia Pacific Bio-pharma Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Bio-pharma by Type
8.3 Asia Pacific Bio-pharma by Application
8.4 Asia Pacific Bio-pharma by Company
9 Central & South America
9.1 Central & South America Bio-pharma by Countries
9.1.1 Central & South America Bio-pharma Sales by Countries
9.1.2 Central & South America Bio-pharma Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Bio-pharma by Type
9.3 Central & South America Bio-pharma by Application
9.4 Central & South America Bio-pharma by Company
10 Middle East and Africa
10.1 Middle East and Africa Bio-pharma by Countries
10.1.1 Middle East and Africa Bio-pharma Sales by Countries
10.1.2 Middle East and Africa Bio-pharma Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Bio-pharma by Type
10.3 Middle East and Africa Bio-pharma by Application
10.4 Middle East and Africa Bio-pharma by Company
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Bio-pharma
11.1.4 Bio-pharma Product Description
11.1.5 Recent Development
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Bio-pharma
11.2.4 Bio-pharma Product Description
11.2.5 Recent Development
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Bio-pharma
11.3.4 Bio-pharma Product Description
11.3.5 Recent Development
11.4 Sanofi, Amgen
11.4.1 Sanofi, Amgen Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Bio-pharma
11.4.4 Bio-pharma Product Description
11.4.5 Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Bio-pharma
11.5.4 Bio-pharma Product Description
11.5.5 Recent Development
11.6 Merck & Co., Inc
11.6.1 Merck & Co., Inc Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Bio-pharma
11.6.4 Bio-pharma Product Description
11.6.5 Recent Development
11.7 Biogen Idec
11.7.1 Biogen Idec Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Bio-pharma
11.7.4 Bio-pharma Product Description
11.7.5 Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Bio-pharma
11.8.4 Bio-pharma Product Description
11.8.5 Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Bio-pharma
11.9.4 Bio-pharma Product Description
11.9.5 Recent Development
11.10 Novartis AG GlaxoSmithKline Plc
11.10.1 Novartis AG GlaxoSmithKline Plc Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Bio-pharma
11.10.4 Bio-pharma Product Description
11.10.5 Recent Development
11.11 Bristol-Myers Squibb Company
11.12 AstraZeneca PLC
11.13 Abbott Laboratories
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Bio-pharma Raw Material
13.1.2 Bio-pharma Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Bio-pharma
Figure Global Bio-pharma Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Bio-pharma Production Market Share by Types (Product Category) in 2017
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Recombinant Proteins Product Picture
Table Major Manufacturers of Recombinant Proteins
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Table Major Manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure Interferons Product Picture
Table Major Manufacturers of Interferons
Figure Recombinant Human Insulin Product Picture
Table Major Manufacturers of Recombinant Human Insulin
Figure Erythropoietin Product Picture
Table Major Manufacturers of Erythropoietin
Figure Vaccines Product Picture
Table Major Manufacturers of Vaccines
Figure Growth Hormones Product Picture
Table Major Manufacturers of Growth Hormones
Figure Purified Proteins Product Picture
Table Major Manufacturers of Purified Proteins
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Bio-pharma Market Size Growth Rate by Application 2018-2025 (K Pcs)
Figure Metabolic Disorders
Figure Oncology
Figure Neurological Disorders
Figure Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases
Figure Others
Figure Bio-pharma Report Years Considered
Figure Global Bio-pharma Market Size 2016-2025 (Million US$)
Figure Global Bio-pharma Sales 2016-2025 (K Pcs)
Table Global Bio-pharma Market Size by Regions 2016-2025 (K Pcs) & (Million US$)
Table Global Bio-pharma Sales by Regions 2016-2025 (K Pcs)
Table Global Bio-pharma Sales Market Share by Regions 2016-2025
Figure Global Bio-pharma Sales Market Share by Regions 2016-2025
Figure 2017 Global Bio-pharma Sales Market Share by Regions
Table Global Bio-pharma Revenue by Regions 2016-2025 (Million US$)
Table Global Bio-pharma Revenue Market Share by Regions 2016-2025
Figure Global Bio-pharma Revenue Market Share by Regions 2016-2025
Figure 2017 Global Bio-pharma Revenue Market Share by Regions
Table Global Bio-pharma Sales by Manufacturers (2016-2018) (K Pcs)
Table Global Bio-pharma Sales Share by Manufacturers (2016-2018)
Figure Global Bio-pharma Sales Share by Manufacturers in 2017
Table Bio-pharma Revenue by Manufacturers (2016-2018) (Million US$)
Table Bio-pharma Revenue Share by Manufacturers (2016-2018)
Figure Bio-pharma Value Share by Manufacturers in 2017
Table Global Bio-pharma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Bio-pharma Price (2016-2018) (USD/Pcs)
Table Bio-pharma Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Bio-pharma Product Category
Table Date of International Manufacturers Enter into Bio-pharma Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Bio-pharma Sales by Type (2016-2025) (K Pcs)
Table Global Bio-pharma Sales Share by Type (2016-2025)
Figure Global Bio-pharma Sales Market Share by Type (2016-2025)
Figure Global Bio-pharma Sales Market Share by Type in 2017
Table Global Bio-pharma Revenue by Type (2016-2025) (Million US$)
Table Global Bio-pharma Revenue Share by Type (2016-2025)
Figure Global Bio-pharma Revenue Market Share by Type (2016-2025)
Figure Global Bio-pharma Revenue Market Share by Type in 2017
Table Bio-pharma Price by Type 2013-2018 (USD/Pcs)
Table Global Bio-pharma Sales by Application (2016-2025) (K Pcs)
Table Global Bio-pharma Sales Share by Application (2016-2025)
Figure Global Sales Bio-pharma Market Share by Application (2016-2025)
Figure Global Sales Bio-pharma Market Share by Application (2016-2025)
Figure North America Bio-pharma Sales Growth Rate 2016-2025 (K Pcs)
Figure North America Bio-pharma Revenue Growth Rate 2016-2025 (Million US$)
Table North America Bio-pharma Sales by Countries (2016-2025) (K Pcs)
Table North America Bio-pharma Sales Market Share by Countries (2016-2025)
Figure 2017 North America Bio-pharma Sales Market Share by Countries
Table North America Bio-pharma Revenue by Countries (2016-2025) (Million US$)
Table North America Bio-pharma Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Bio-pharma Revenue Market Share by Countries
Figure United States Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure United States Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Canada Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Mexico Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Table North America Bio-pharma Sales by Type (2016-2025) (K Pcs)
Table North America Bio-pharma Sales Market Share by Type (2016-2025)
Figure 2017 North America Bio-pharma Market Share by Type
Table North America Bio-pharma Sales by Application (2016-2025) (K Pcs)
Table North America Bio-pharma Sales Market Share by Application (2016-2025)
Figure 2017 North America Bio-pharma Market Share by Application
Table North America Bio-pharma Sales by Company (2016-2018) (K Pcs)
Table North America Bio-pharma Sales Market Share by Company (2016-2018)
Figure North America Bio-pharma Sales Market Share by Company in 2017
Figure Europe Bio-pharma Sales Growth Rate 2016-2025 (K Pcs)
Figure Europe Bio-pharma Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Bio-pharma Sales by Countries (2016-2025) (K Pcs)
Table Europe Bio-pharma Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Bio-pharma Sales Market Share by Countries
Table Europe Bio-pharma Revenue by Countries (2016-2025) (Million US$)
Table Europe Bio-pharma Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Bio-pharma Revenue Market Share by Countries
Figure Germany Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Germany Bio-pharma Revenue Growth Rate (2016-2025) (K Pcs)
Figure France Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure France Bio-pharma Revenue Growth Rate (2016-2025) (K Pcs)
Figure UK Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure UK Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Italy Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Russia Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Bio-pharma Sales by Type (2016-2025) (K Pcs)
Table Europe Bio-pharma Sales Market Share by Type (2016-2025)
Figure 2017 Europe Bio-pharma Market Share by Type
Table Europe Bio-pharma Sales by Application (2016-2025) (K Pcs)
Table Europe Bio-pharma Sales Market Share by Application (2016-2025)
Figure 2017 Europe Bio-pharma Market Share by Application
Table Europe Bio-pharma Sales by Company (2016-2018) (K Pcs)
Table Europe Bio-pharma Sales Market Share by Company (2016-2018)
Figure Europe Bio-pharma Sales Market Share by Company in 2017
Figure Asia Pacific Bio-pharma Sales Growth Rate 2016-2025 (K Pcs)
Figure Asia Pacific Bio-pharma Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Bio-pharma Sales by Countries (2016-2025) (K Pcs)
Table Asia Pacific Bio-pharma Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Bio-pharma Sales Market Share by Countries
Table Asia Pacific Bio-pharma Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Bio-pharma Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Bio-pharma Revenue Market Share by Countries
Figure China Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure China Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Japan Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Korea Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure India Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure India Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Australia Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Indonesia Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Malaysia Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Philippines Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Thailand Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Vietnam Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Singapore Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Bio-pharma Sales by Type (2016-2025) (K Pcs)
Table Asia Pacific Bio-pharma Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Bio-pharma Market Share by Type
Table Asia Pacific Bio-pharma Sales by Application (2016-2025) (K Pcs)
Table Asia Pacific Bio-pharma Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Bio-pharma Market Share by Application
Table Asia Pacific Bio-pharma Sales by Company (2016-2018) (K Pcs)
Table Asia Pacific Bio-pharma Sales Market Share by Company (2016-2018)
Figure Asia Pacific Bio-pharma Sales Market Share by Company in 2017
Figure Central & South America Bio-pharma Sales Growth Rate 2016-2025 (K Pcs)
Figure Central & South America Bio-pharma Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Bio-pharma Sales by Countries (2016-2025) (K Pcs)
Table Central & South America Bio-pharma Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Bio-pharma Sales Market Share by Countries
Table Central & South America Bio-pharma Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Bio-pharma Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Bio-pharma Revenue Market Share by Countries
Figure Brazil Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Brazil Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Argentina Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Bio-pharma Sales by Type (2016-2025) (K Pcs)
Table Central & South America Bio-pharma Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Bio-pharma Market Share by Type
Table Central & South America Bio-pharma Sales by Application (2016-2025) (K Pcs)
Table Central & South America Bio-pharma Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Bio-pharma Market Share by Application
Table Central & South America Bio-pharma Sales by Company (2016-2018) (K Pcs)
Table Central & South America Bio-pharma Sales Market Share by Company (2016-2018)
Figure Central & South America Bio-pharma Sales Market Share by Company in 2017
Figure Middle East and Africa Bio-pharma Sales Growth Rate 2016-2025 (K Pcs)
Figure Middle East and Africa Bio-pharma Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Bio-pharma Sales by Countries (2016-2025) (K Pcs)
Table Middle East and Africa Bio-pharma Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Bio-pharma Sales Market Share by Countries
Table Middle East and Africa Bio-pharma Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Bio-pharma Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Bio-pharma Revenue Market Share by Countries
Figure GCC Countries Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure GCC Countries Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Turkey Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure Egypt Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Bio-pharma Sales Growth Rate (2016-2025) (K Pcs)
Figure South Africa Bio-pharma Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Bio-pharma Sales by Type (2016-2025) (K Pcs)
Table Middle East and Africa Bio-pharma Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Bio-pharma Market Share by Type
Table Middle East and Africa Bio-pharma Sales by Application (2016-2025) (K Pcs)
Table Middle East and Africa Bio-pharma Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Bio-pharma Market Share by Application
Table Middle East and Africa Bio-pharma Sales by Company (2016-2018) (K Pcs)
Table Middle East and Africa Bio-pharma Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Bio-pharma Sales Market Share by Company in 2017
Table Pfizer Company Details
Table Pfizer Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table F. Hoffmann-La Roche AG Company Details
Table F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche AG Recent Development
Table Johnson & Johnson Services Company Details
Table Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Johnson & Johnson Services Recent Development
Table Sanofi, Amgen Company Details
Table Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Sanofi, Amgen Recent Development
Table AbbVie Company Details
Table AbbVie Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table AbbVie Recent Development
Table Merck & Co., Inc Company Details
Table Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Merck & Co., Inc Recent Development
Table Biogen Idec Company Details
Table Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Biogen Idec Recent Development
Table Bayer AG Company Details
Table Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Bayer AG Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Eli Lilly and Company Recent Development
Table Novartis AG GlaxoSmithKline Plc Company Details
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)
Table Novartis AG GlaxoSmithKline Plc Recent Development
Table Bristol-Myers Squibb Company Company Details
Table AstraZeneca PLC Company Details
Table Abbott Laboratories Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Bio-pharma Value Chain
Table Typical Suppliers of Key Bio-pharma Raw Material
Table Bio-pharma Customers List
Table Bio-pharma Sales Channels
Table Bio-pharma Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources 
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
